Regulatory alerts
Company-led medicines recall: PCCA Limited, Ketamine 50mg in 5ml Oral Solution and Ketamine 100mg in 5ml Oral Solution (unlicensed medicines)
PCCA Limited have been made aware of an issue with the appearance of the product.
NICE recommends risankizumab for active psoriatic arthritis in adults
NICE final draft guidance recommends risankizumab, alone or with methotrexate, for active psoriatic arthritis in adults whose disease has not responded well enough to DMARDs or who cannot tolerate them.
Roxadustat recommended for symptomatic anaemia associated with CKD
NICE recommends roxadustat for treating symptomatic anaemia associated with chronic kidney disease in final draft guidance.
